The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...

The task ahead of Vertex now is to migrate patients already ... (liraglutide), used to treat type 2 diabetes, from India's Hikma Pharma. Victoza has been largely superseded by Novo Nordisk's ...

IMS Health points to Vertex as being an example of this, the specialist US firm choosing to launch its first-in-class cystic fibrosis drug Kalydeco around the world without a big pharma partner.

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

Vertex announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for ALYFTREK, a once-daily ...

Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

India's Sun Pharmaceutical Industries said on Monday that it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, in a deal valued at up to $355 million.

The stock's fall snapped a four-day winning streak.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a prominent player in the biotechnology industry with a market capitalization of $123.2 billion, finds itself at a critical... David Altshuler ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...